Here are three stocks added to the Zacks Rank #24 (Strong Sell) List today:
Akebia Therapeutics, Inc. AKBA is a biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 26.3% downward over the last 60 days.
Coca-Cola FEMSA, S.A.B. de C.V. KOF is a franchise bottling company. The Zacks Consensus Estimate for its current year earnings has been revised 7.9% downward over the last 60 days.
Guess?, Inc. GES is an apparel and accessories company. The Zacks Consensus Estimate for its current year earnings has been revised 27% downward over the last 60 days.
View the entire Zacks Rank #5 List.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Guess?, Inc. (GES): Free Stock Analysis Report
Coca Cola Femsa S.A.B. de C.V. (KOF): Free Stock Analysis Report
Akebia Therapeutics, Inc. (AKBA): Free Stock Analysis Report
/Microsoft%20sign%20at%20the%20headquarters%20by%20VDB%20Photos%20via%20Shutterstock.jpg)
